HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anti-interleukin-1 agents: a new class of drugs for recurrent pericarditis. A practical guide for cardiologists].

Abstract
Anti-interleukin (IL)-1 agents have been developed for the treatment of autoinflammatory diseases characterized by overproduction of IL-1. Idiopathic recurrent pericarditis with inflammatory phenotype (fever, leukocytosis, and elevation of C-reactive protein) has similar features and responds well to this treatment. At present, in Italy, prescription of anakinra is possible for idiopathic recurrent pericarditis with corticosteroid dependence and colchicine resistance. Anakinra is a recombinant antagonist of IL-1 receptor and blocks either IL-1α (released from pericardial cells) or IL-1β (derived for inflammatory cells, during pericarditis). Anakinra is prescribed at the dose of 2 mg/kg/day subcutaneously up to 100 mg/day subcutaneously for at least 3 to 6 months with subsequent tapering. Anakinra allows a quick control of symptoms after 1-2 doses and a fast and safe tapering and withdrawal of corticosteroids. Colchicine can be used together with anakinra. The most common side effect is represented by local skin injection site reactions after 1-2 weeks of therapy. These reactions are usually transient and can be treated by anti-histamines and topical corticosteroids. Less common side effects include elevation of transaminases (4-5%), cutaneous or respiratory infections (2-3%), and leukopenia (1-3%). Side effects are rarely responsible for permanent discontinuation of therapy. The aim of the present review is to provide a practical guide on the use of these drugs for cardiologists, who are often not familial with this new therapy for pericarditis.
AuthorsMassimo Imazio, George Lazaros, Marco Gattorno, Antonio Abbate, Antonio Brucato
JournalGiornale italiano di cardiologia (2006) (G Ital Cardiol (Rome)) Vol. 22 Issue 10 Pg. 833-843 (Oct 2021) ISSN: 1972-6481 [Electronic] Italy
Vernacular TitleGli antagonisti dell’interleuchina-1: una nuova classe di farmaci per il trattamento della pericardite ricorrente. Una guida pratica per il cardiologo clinico.
PMID34570117 (Publication Type: Journal Article, Review)
Chemical References
  • Interleukin-1
  • Pharmaceutical Preparations
  • Colchicine
Topics
  • Cardiologists
  • Colchicine
  • Humans
  • Interleukin-1
  • Pericarditis (drug therapy)
  • Pharmaceutical Preparations
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: